Andrea Schneider

Dr. Andrea Schneider is an active faculty member at the UC Davis MIND Institute and holds a position in the Department of Pediatrics at University of California, Davis. Her work bridges clinical care and research, focusing on neurodevelopmental and neurodegenerative disorders such as Fragile X Syndrome and Autism Spectrum Disorders. She leads the ACCESS Program (Acquiring Career, Coping, Executive Control, and Social Skills) for adults with autism and contributes to the LEND Program (Leadership and Education in Neurodevelopmental Disabilities) through psychoeducational workshops.

• Ph.D. in Psychology, University of Potsdam, Germany (2007)
• B.Sc./M.Sc. in Psychology, University of Potsdam (2001)
• Postdoctoral Fellowship in Fragile X Syndrome/Autism Spectrum Disorders, UC Davis MIND Institute (2008-2011)

Her research emphasizes psychophysiological measures like EEG, ERP, HRV, and PPI to detect brain processing changes in neurodevelopmental and neurodegenerative disorders. Key publications include studies on EEG signal complexity, FXTAS progression, and therapeutic interventions like metformin and sulforaphane. She has received the 2004 Prize of the Scientific Council of the LOS (Dyslexia) Institutes in Germany.

Recent articles highlight her expertise in biomarker development (e.g., EEG, ERG), genetic correlates of cognition, and clinical programs for neurodiverse populations. Ongoing studies explore the intersection of AAV vector production, metformin efficacy, and digital health applications in neurodevelopmental research. Her philosophy prioritizes evidence-based, person-centered care and family collaboration.